Understanding the genetic changes in a specific type of small cell lung cancer.
Lineage evolution of a small cell lung cancer epigenomic subtype signified by NKX2-1
This study is looking at the genetic changes in small cell lung cancer to find out how it behaves differently and to discover new ways to treat it, which could help patients get more personalized and effective therapies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11050205 on NIH RePORTER |
What this research studies
This research investigates the genetic and epigenetic changes in small cell lung cancer (SCLC), a particularly aggressive form of lung cancer. By analyzing the molecular subtypes of SCLC, the study aims to uncover distinct biological behaviors and potential therapeutic targets. The approach involves large-scale genetic studies and epigenetic profiling to enhance the understanding of SCLC pathogenesis and improve treatment options. Patients may benefit from insights that could lead to more personalized and effective therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with small cell lung cancer, particularly those with advanced or metastatic disease.
Not a fit: Patients with non-small cell lung cancer or those without a diagnosis of lung cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and outcomes for patients with small cell lung cancer.
How similar studies have performed: Previous research has shown promise in identifying genetic changes in lung cancer, but this specific focus on SCLC subtypes is relatively novel.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Watanabe, Hideo — Icahn School of Medicine at Mount Sinai
- Study coordinator: Watanabe, Hideo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.